These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 16130444)

  • 41. Treating nonalcoholic fatty liver disease.
    Méndez-Sánchez N; Arrese M; Zamora-Valdés D; Uribe M
    Liver Int; 2007 Nov; 27(9):1157-65. PubMed ID: 17919226
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alcoholic and nonalcoholic forms of fatty liver disease.
    Forgione A; Miele L; Cefalo C; Gasbarrini G; Grieco A
    Minerva Gastroenterol Dietol; 2007 Mar; 53(1):83-100. PubMed ID: 17415346
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nonalcoholic fatty liver disease.
    Bayard M; Holt J; Boroughs E
    Am Fam Physician; 2006 Jun; 73(11):1961-8. PubMed ID: 16770927
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nonalcoholic steatohepatitis.
    Sanyal A
    Indian J Gastroenterol; 2001 Mar; 20 Suppl 1():C64-70. PubMed ID: 11293184
    [No Abstract]   [Full Text] [Related]  

  • 45. Clinical update on non-alcoholic fatty liver disease and steatohepatitis.
    Bugianesi E; Bellentani S; Bedogni G; Tiribelli C;
    Ann Hepatol; 2008; 7(2):157-60. PubMed ID: 18626435
    [No Abstract]   [Full Text] [Related]  

  • 46. [Current knowledge of nonalcoholic steatohepatitis].
    Clemente Ricote G; García Monzón C
    Med Clin (Barc); 2003 Jun; 121(3):102-8. PubMed ID: 12855136
    [No Abstract]   [Full Text] [Related]  

  • 47. New diagnostic and treatment approaches in non-alcoholic fatty liver disease (NAFLD).
    Ali R; Cusi K
    Ann Med; 2009; 41(4):265-78. PubMed ID: 19353360
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Nonalcoholic steatohepatitis].
    Poralla T
    Dtsch Med Wochenschr; 2005 Dec; 130 Suppl 5():S225-6. PubMed ID: 16435718
    [No Abstract]   [Full Text] [Related]  

  • 49. Hypertension and fatty liver: guilty by association?
    Brookes MJ; Cooper BT
    J Hum Hypertens; 2007 Apr; 21(4):264-70. PubMed ID: 17273155
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Case report: nonalcoholic steatohepatitis in a teenage girl with type 2 diabetes.
    Nadeau K; Klingensmith G; Sokol RJ
    Curr Opin Pediatr; 2003 Feb; 15(1):127-31. PubMed ID: 12544284
    [No Abstract]   [Full Text] [Related]  

  • 51. [Alcoholic and nonalcoholic steatohepatitis: the same disease! II. Management].
    Spahr L; Hadengue A
    Rev Med Suisse; 2005 Sep; 1(31):2032-4. PubMed ID: 16212005
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Nonalcoholic steatohepatitis--an overlooked diagnosis so far].
    Schlichting P
    Ugeskr Laeger; 2003 Mar; 165(11):1113. PubMed ID: 12677984
    [No Abstract]   [Full Text] [Related]  

  • 53. Keratin-18 as a marker of steatohepatitis.
    Gonzalez-Quintela A; Lojo S; Otero E; Perez LF
    Hepatology; 2007 Feb; 45(2):545. PubMed ID: 17256723
    [No Abstract]   [Full Text] [Related]  

  • 54. Definitive diagnosis and assessment of risk for nonalcoholic fatty liver disease in children and adolescents.
    Schwimmer JB
    Semin Liver Dis; 2007 Aug; 27(3):312-8. PubMed ID: 17682977
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Invasive and non-invasive investigations for non-alcoholic steatohepatitis (NASH): the need for biochemical markers.
    Ahmed MH
    Scand J Gastroenterol; 2006 Mar; 41(3):372. PubMed ID: 16497631
    [No Abstract]   [Full Text] [Related]  

  • 56. [Nonalcoholic steatohepatitis: pathogenesis and treatment].
    Park SH
    Korean J Hepatol; 2008 Mar; 14(1):12-27. PubMed ID: 18367854
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Citrin deficiency as a cause of chronic liver disorder mimicking non-alcoholic fatty liver disease.
    Komatsu M; Yazaki M; Tanaka N; Sano K; Hashimoto E; Takei Y; Song YZ; Tanaka E; Kiyosawa K; Saheki T; Aoyama T; Kobayashi K
    J Hepatol; 2008 Nov; 49(5):810-20. PubMed ID: 18620775
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Fatty liver].
    Tanaka N
    Nihon Rinsho; 2001 Feb; 59 Suppl 2():707-9. PubMed ID: 11351676
    [No Abstract]   [Full Text] [Related]  

  • 59. Review article: non-alcoholic fatty liver disease and hepatitis C--risk factors and clinical implications.
    Sanyal AJ
    Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():48-51. PubMed ID: 16225473
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Liver diseases in the elderly: an update.
    Floreani A
    Dig Dis; 2007; 25(2):138-43. PubMed ID: 17468549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.